F93-26872-23867
4 vaccinations
12 coded responses
24 check-ins
11 free-text entries
6 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 420 / KY
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Moderna
-
2021-01-14
Survey response — day 0, dose 1MedDRA: Liver transplant, Pre-existing disease — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessFree text: Immuno suppressed liver transplantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tirednessFree text: Glucose level 150 points above normal with a significantly lower carb intake. Essentially no exercise today. Symptoms similar to the flu.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Glucose level 130 points above my established normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased, Blood insulin increased — Feeling: Good · HeadacheFree text: Glucose readings remain about 20 points higher than average following an increase in insulin. These numbers are lower than yesterday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased — Feeling: Good · Headache, Muscle or body achesFree text: Very high glucose150 dg/ml.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Glucose level has returned to normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-21
Survey response — day 7, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Spiking glucose following very light mealMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-12
Dose 2 — Moderna
- 2021-02-18
-
2021-02-19
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-24
- 2021-03-26
- 2021-05-14
-
2021-08-13
Survey response — 6 months, dose 2MedDRA: Hospitalisation, Infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Hospital admitted for 4 days. Unknown pathogen. Recovering slowly.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-16
Dose 3 — Moderna
- 2021-08-18
- 2021-11-15
-
2022-02-14
Dose 4 — Moderna
-
2022-02-14
Survey response — 6 months, dose 3MedDRA: Asthenia, Feeling cold, Headache, Lymphoma, Sluggishness, Systemic scleroderma — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Sluggish, headache, loss of energy, physically cold. Cancer of lymph nodes, SSC on scalpMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-02-16
-
2022-05-16
Survey response — 3 months, dose 4MedDRA: Lymphadenectomy, Lymphoma, Radiotherapy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Lymph node SCC followed by left lymph node dissection. Started radiation treatments last week.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-05-17
Call successfulCompleted over the phone
-
2022-05-17
Call successfulCompleted over the phone
-
2022-05-17
Call successfulCompleted over the phone
-
2022-05-17
Call successfulCompleted over the phone
-
2022-08-15
Survey response — 6 months, dose 4MedDRA: Ageusia, Asthenia, Decreased appetite — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Loss of taste and no appetite. Lack of energy.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-15
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-14
Survey response — 12 months, dose 4MedDRA: Herpes zoster, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2024-11
-
2023-02-14
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2023-02-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-08-16 | Moderna | No |
| 4 | 2022-02-14 | Moderna | No |
Call center
6 call center cases
5 successful · 1 unsuccessful
VAERS report filed, before or during a call: 4
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Immuno suppressed liver transplant
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Glucose level 150 points above normal with a significantly lower carb intake. Essentially no exercise today. Symptoms similar to the flu.
Systemic reaction (other): Glucose level 130 points above my established normal
Systemic reaction (other): Glucose readings remain about 20 points higher than average following an increase in insulin. These numbers are lower than yesterday.
Systemic reaction (other): Very high glucose150 dg/ml.
Systemic reaction (other): Glucose level has returned to normal.
Release 2 — day 7, dose 1
Systemic reaction (other): Spiking glucose following very light meal
Release 9 — 6 months, dose 2
Symptoms: Hospital admitted for 4 days. Unknown pathogen. Recovering slowly.
Release 11 — 6 months, dose 3
Symptoms: Sluggish, headache, loss of energy, physically cold. Cancer of lymph nodes, SSC on scalp
Release 11 — 3 months, dose 4
Symptoms: Lymph node SCC followed by left lymph node dissection. Started radiation treatments last week.
Release 12 — 6 months, dose 4
Symptoms: Loss of taste and no appetite. Lack of energy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Feeling cold | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Hospitalisation | ✓ | · | ✓ |
| SD | Infection | ✓ | · | ✓ |
| SD | Lymphadenectomy | · | · | ✓ |
| SD | Lymphoma | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Radiotherapy | · | · | ✓ |
| SD | Sluggishness | · | · | ✓ |
| SD | Systemic scleroderma | · | · | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Blood insulin increased | ✓ | ✓ | ✓ |
| SRO | Liver transplant | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release